Unlocking Global Market Expansion Beyond the US

Kipp has more than 30 years’ experience in biopharma commercial leadership. He is a Global Sales and Marketing Leader for integrated, end-to-end, brand commercialization with a focus on de-risking assets, developing strategies for competitive advantage and driving executional efficiencies. ​

Kipp has diverse therapeutic expertise ranging from ultra rare conditions, vaccines, infectious disease, oncology, cardiology, neurology, dermatology, urology and women’s health, in both specialty care and general care settings. He led the blockbuster launch of Viagra into Europe. He has earned multiple industry awards: AdAge’s prestigious Marketer of the Year; multiple MM&M awards; and global recognition as one of the world’s maverick marketers. Kipp has worked within start up, mid-size and large biopharma companies across the entire brand life cycle continuum and assisted companies in successfully launching, partnering and divesting brand assets. ​

Within Syneos Health, Kipp is a connector, and brings together the best resources to optimally drive brand success. He brings energy, curiosity, creativity, disciplined planning and execution to practically accomplish proven results.

Executive marketing leader with over 30 years in the biopharma industry with expertise in global market access, pharmaceutical and vaccine brand marketing, strategic planning, commercial insights generation, and commercial account sales. As the Vice President of Global Market Access at Syneos Health for the past 6 years, Robert leads the Pricing, Reimbursement & Market Access area in the Full-Service Commercial business unit. Staffed with a team of market access experts, Robert oversees the design and development of innovative solutions that integrate Syneos Health’s commercial capabilities in Market Access to address our client’s unique needs.  ​

Prior to joining Syneos Health, Robert had a long tenure at Merck, progressing through brand marketing, hospital sales, and market access positions in rare diseases, oncology, ophthalmics, infectious disease, cardiology, respiratory, and woman's health. Senior positions at Merck included leading the Pricing and Access Launch Center of Excellence (8 launches) and the Global Vaccine Market Research department (portfolio of 10 promoted vaccines).

Mitra brings over 25 years of pharmaceutical experience to Syneos Health. He is a physician with specialist training in endocrinology and has held leadership positions at Pfizer, Novartis and Bristol Myers Squibb.

He has led all aspects of global clinical development including clinical trial design and execution from phase 1 to registration and beyond.

Mitra has robust experience negotiating with regulatory authorities and with payors. He has extensive medical affairs experience in US and EU with a track record of collaboratively launching innovative therapies in multiple therapeutic areas.

Anshu Sawhney brings nearly 25 years of leadership experience in medical affairs, marketing, and clinical pharmacy within the biopharmaceutical industry. As a Global Medical Affairs Leader at Syneos Health, Anshu partners with small to mid-sized biopharma companies to guide their transition from clinical development to commercialization—often supporting the launch of their first asset.

Prior to joining Syneos Health, Anshu held leadership roles at Genentech, where she oversaw the launch of a newly acquired pulmonary asset and led the seamless integration of patient and access services. Her therapeutic expertise spans oncology, immunology, respiratory, cardiology, dermatology, and rare and ultra-rare diseases.

Before entering the industry, Anshu served as an investigational pharmacist at MD Anderson Cancer Center, where she managed over 1,000 active clinical trials. She also practiced as a general practice and oncology pharmacist in institutional settings across the NY/NJ area.